Infection and Drug Resistance · 2013 · 20 citations · 14 references
Life SciencesInfectious DiseasesMicrobiologyAntimicrobial ResistanceEnzymologyMedical MicrobiologyAntibacterial ResistanceAntibacterial TherapyAntibiotic ResistanceBeta-lactam ResistanceCarbapenem ResistanceResistance In Gram-positive BacteriaAmpc Beta-lactamase-mediated ResistanceAmpc Beta-lactamasesBeta-lactamase GenesBeta-lactamase InhibitorsBeta-lactamase Mediated ResistanceCarbapenemase EnzymesClass A Beta-lactamases
Induction of ampC β-lactamase expression can often compromise antibiotic treatment and is triggered by several β-lactams (such as cefoxitin and imipenem) and by the β-lactamase inhibitor clavulanic acid. The novel β-lactamase inhibitor avibactam (NXL104) is a potent inhibitor of both class A and class C enzymes. The potential of avibactam for induction of ampC expression in Enterobacter cloacae was investigated by ampC messenger ribonucleic acid quantitation. Cefoxitin and clavulanic acid were confirmed as ampC inducers, whereas avibactam was found to exert no effect on ampC expression. Thus, avibactam is unlikely to diminish the activity of any partner β-lactam antibiotic against AmpC-producing organisms.
14
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
PubMed · 1997 · 66.6K citations
David M. Livermore, Trevor Winstanley, Kevin Shannon · Journal of Antimicrobial Chemotherapy · 2001 · 261 citations · Full text
Veterinary Medicine, Infectious Diseases, Antimicrobial Resistance +16